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Abstract 
Chromosomal abnormalities are often identified in people with neurodevelopmental 
disorders including intellectual disability, autism and epilepsy. Ring chromosomes, 
which usually involve gene copy number loss, are formed by fusion of sub-telomeric 
or telomeric chromosomal regions. Some ring chromosomes, including ring 14, 17 
and 20, are strongly associated with seizure disorders.  We report an individual with 
a ring chromosome 17 (r(17)(p13.3q25.3))  with a terminal 17q25.3 deletion and 
no short arm copy number loss, with a phenotype characterized by intellectual 
disability and drug-resistant epilepsy including a propensity for non-convulsive 
status epilepticus.  
 
Established facts: Ring 17 syndrome is a rare condition with different clinical 
features depending on whether the Miller-Dieker Critical Region (MDCR), is 
involved. Ring 17 syndrome not including the MDCR is considered milder but only 
12 cases have been previously described.. The genetic and clinical evaluation of this 
condition might be challenging. 
Novel Insights: The reported phenotype includes growth delay, intellectual 
disability, seizures, café au lait skin lesions, minor dysmorphism and a flecked 
retina. Only two previous cases provide description of the epileptic phenotype. We 
report in detail the epilepsy-related features of an individual with ring 17 syndrome 
not involving the MDCR helping to delineate a possible common phenotype of this 
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condition. The present case has also been assessed through Exome Sequencing to 
exclude the possibility that known possible genetic factors might have influenced 
the epileptic phenotype. A comparison with the linear 17q deletion is also discussed. 
 
Key words: copy number variation, non-convulsive status epilepticus, epilepsy co-
morbidity  
 
 
Introduction 
Chromosomal abnormalities identified by newer cytogenetic technologies are 
emerging as an important genetic association of some epilepsies (Xiang et al., 2010). 
In recent years, the increasing number of reports of people with overlapping genetic 
changes and phenotypes has allowed the delineation of new syndromes 
(http://decipher.sanger.ac.uk/) (Firth et al., 2009).   
Ring chromosomes have been described with all human autosomes.  Associated 
phenotypes vary greatly depending on the chromosomes involved, the size of 
deleted segments and the presence or absence of mosaicism (Wyandt, 1988). Some 
ring chromosomes, such as ring 20 and ring 14, are associated with a specific 
seizure phenotype, including status epilepticus. Ring 17 syndrome is a rare 
condition with different clinical features depending on whether the Miller-Dieker 
Critical Region (MDCR), which maps to the short arm of chromosome 17 at 17p13.3, 
is involved (Shashi et al., 2003). When this region is deleted (with or without ring 17 
chromosome formation), the phenotype, includes lissencephaly, severe intellectual 
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disability and typical facial dysmorphism (Shashi et al., 2003). Epilepsy has also 
been reported but a definite phenotype has not been described (Shimojima et al., 
2010).  If the MDCR  region is not involved in ring 17 formation, the phenotype is 
milder and may include growth delay, intellectual disability, seizures, café au lait 
skin lesions, minor dysmorphism and  a flecked retina (Charles et al., 1991; Shashi et 
al., 2003; Surace et al., 2009).  
 
 Only 12 cases of ring chromosome 17 without involvement of the MDCR have been 
described (de Palma et al., 2015; Endo et al., 1999; Gass & Taney, 1994; Kumari et 
al., 2009; Qazi et al., 1979; Ricard-Mousnier et al., 2007; Shashi et al., 2003; Surace et 
al., 2009). Epilepsy has been described in detail in only two such cases, with focal 
seizures from sleep and prolonged non-convulsive status epilepticus in wakefulness 
(de Palma et al., 2015; Ricard-Mousnier et al., 2007). We describe the clinical and 
EEG features of a further case with ring chromosome 17. 
 
 
 
Clinical report 
This 31 year old woman is the second child of healthy unrelated parents. There is no 
family history of epilepsy or any other neurological condition. She was born at term 
through natural delivery weighing 2.9kg (10th percentile).  She remained 
consistently below the 25th percentile for height afterwards. She initially attained 
normal developmental milestones, being able to speak two languages.  
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Seizure onset was at age four years, when she developed clonic seizures in sleep, 
followed by different types of seizures in wakefulness.  With seizure onset, she lost 
her ability to speak, which was initially regained when the seizures were well 
controlled.  When seizures recurred and increased in frequency, she lost her 
language ability permanently.  
She has had multiple seizure types including generalized tonic-clonic seizures, 
clonic seizures, tonic seizures from sleep and, complex partial seizures which are 
the commonest type. She has had treatments with many drugs including 
lamotrigine, phenobarbital, zonisamide, valproate, phenytoin, carbamazepine, 
vigabatrin, topiramate, levetiracetam , clobazam, clonazepam, gabapentin and 
felbamate.  She derived some benefit only from lamotrigine and phenobarbital, 
which reduced seizure frequency by about 50%. The ketogenic was abandoned as 
she could not tolerate it.   
 
At age ten, EEG showed marked epileptiform abnormality bi-laterally but with some 
left sided predominance. A brain MRI scan at age of 11 was normal. A subsequent 
interictal SPECT suggested asymmetry of the temporal lobes with the right showing 
reduced perfusion in the anterior portion, extending posteriorly. 
 
She was referred at age of 24. She had moderate intellectual disability. She could 
walk with assistance, did not speak and did not have anal sphincter control.  
Examination disclosed multiple café au lait patches on the back and abdomen and 
multiple white patches on the chest; no obvious dysmorphism was noted.  She had 
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daily complex partial seizures, a median of three monthly generalized tonic-clonic 
seizures and 1-2 monthly tonic seizures from sleep.. Complex partial seizures were 
characterized by sudden arrest of activity, staring gaze, hand wringing and lip 
smacking usually brief lasting 1-2 minutes but associated with significant post-ictal 
tiredness.  On referral, her treatment was lamotrigine 375 mg/day, zonisamide 300 
mg/day and phenobarbital 30 mg/day. Phenobarbital and zonisamide were 
discontinued and lamotrigine increased to 550 mg/day. Her social interaction and 
alertness improved without worsening of seizure frequency.  
 
At age 28, she was admitted due to an increased seizure frequency and cognitive 
decline. EEG showed almost continuous bilateral bursts of spike and wave 
complexes over a background of theta/delta activity. No convulsive seizures had 
been documented, but she was much less alert, drowsy and slower than usual 
(Fig.1). A diagnosis of non-convulsive status epilepticus was made and treated with 
benzodiazepines which lead to an improvement.  
 
 
 
Cytogenetics 
Array-CGH analysis using a NimbleGen 135K whole genome v3.0 array chip showed 
a near-terminal interstitial 0.45 Mb microdeletion within 17q25.3 (chr17: 
80,572,212,-80,983,971; the genomic region of the corresponding benign CNV is 
chr17: 44,353,924-44,766,072; HG19; Fig. 2a). No copy number gain or loss was 
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noted on the chromosome 17 short arm. Examination of 30 G-banded metaphases 
and FISH analysis using Cytocell Aquarius 17pter and RP11-567O16 probes 
identified a single ring chromosome  r(17)(p13.3q25.3), in all metaphases examined  
(Fig. 2b). The deletion involved eight OMIM protein-coding genes (FOXK2, WDR45B, 
RAB40B, FN3KRP, FN3K, TBCD, ZNF750, B3GNTL1) (Figure 2c ). Parental FISH 
analysis demonstrated that the ring chromosome had arisen de novo. 
We performed whole exome sequencing (WES) [mean target coverage of 102.27; 
82.6% of bases read at least 30X ]  and interrogated  exonic variants occurring in 
epilepsy-related genes (see Supplementary table). The exonic library was amplified 
by Nextera Exome Kit (Illumina),  and  sequenced on a HiSeq 2500 platform 
(Illumina). After read alignment, candidate genes were analyzed by vcf tools 
(Danecek et al., 2011) and annotated using Annovar. (Wang et al., 2010). None of the 
variants identified were considered pathogenic using  the  criteria applied (see 
supplementary methods for more details).  
 
 
 
Discussion 
Ring chromosome 17 without MDCR involvement is rare  (Charles et al., 1991; 
Chudley et al., 1982; de Palma et al., 2015; Endo et al., 1999; Gass & Taney, 1994; 
Kumari et al., 2009; Qazi et al., 1979; Ricard-Mousnier et al., 2007; Shashi et al., 
2003; Surace et al., 2009).  Epilepsy, although reported in all cases, is well described 
in only two cases, both presenting with nocturnal focal seizures and prolonged 
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diurnal non-convulsive status epilepticus (de Palma et al., 2015; Ricard-Mousnier et 
al., 2007)   Isolated linear 17q deletions  are also rare: thirteen cases are reported in 
the Decipher database (https://decipher.sanger.ac.uk/search?q=znf750#consented-
patients/results). These present with various dysmorphic features and eye 
abnormalities other than a flecked retina. Epilepsy is not described in linear 17q 
deletion. The clinical features of the cases with ring (17) chromosome and linear 
17q deletion are summarized in Tables 1 and 2. 
 
Our case had all the features reported for the other ring (17) cases, although as she 
had not had an ophthalmological review we are not certain if she has a flecked 
retina.  The main clinical symptom was drug-resistant epilepsy which amounted to 
an epileptic encephalopathy with multiple seizures type, especially featuring 
nocturnal tonic seizures and non-convulsive status epilepticus. Language was most 
severely affected, with normal acquisition and subsequent loss. 
 
Clinical features of Landau-Kleffner Syndrome (LKS) and Lennox-Gastaut Syndrome 
(LGS) are present in our case and also in a previously reported case (Ricard-
Mousnier et al., 2007), but the electroclinical features are not consistent with either 
of these conditions.  Non-convulsive status epilepticus was a shared  epilepsy 
phenotype (de Palma et al., 2015).  Detailed data are available from only these three 
cases (our own and ref. 8, 13), but it is possible that polymorphic seizures and non-
convulsive status epilepticus represent the typical presentation of epilepsy in this 
condition. In our view, a ring (17) abnormality should be considered if a child is 
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affected by drug-resistant epilepsy, featuring non-convulsive status epilepticus 
associated with other clinical conditions such as growth delay, intellectual disability, 
café au lait skin lesions, minor dysmorphism or a flecked retina. 
 
  
MDCR involvement in ring chromosome 17 helps predict a homogeneous and severe 
phenotype but less information is available when this region is not involved. Thus, 
to date there is no candidate gene for the epilepsy phenotype in the ring 
chromosome 17 syndrome without MDCR involvement.  There are no reports of 
simple deletions of the long arm of chromosome 17: del(17)(q25.3) to allow  
comparison.  
 
The chromosomal abnormality in our case is quite small (only 0.45 Mb) and only 
includes eight protein-coding genes, five of which are expressed in the brain 
(FN3KRP, FN3K, TBCD, ZNF750, BGNTL1).  Biallelic mutations affecting TBCD have 
been found in a rare condition called Sanjad-Sakati syndrome. Epilepsy has been 
reported in 46% of these individuals but never characterized except in one child 
with generalized tonic-clonic convulsive status (Ahmed-Farag-Elhassanien et al 
2013) (Rajniti Prasad et al 2013)  The exact functions of the other genes are not 
known. Whole exome sequencing did not detect variants predicted to be damaging 
that could possibly explain the phenotype of this individual beyond the ring 
chromosome. 
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Ring chromosomes are chromosomal abnormalities which can arise through the 
fusion of the telomeric regions  with or without loss of genetic material (Wyandt, 
1988).  Rings are invariably unstable, resulting in cumulative somatic mutations 
which may be tissue-specific as a result of secondary imbalances involving the ring 
chromosome.  In a recent series of rings  such secondary imbalances were observed 
in 4/29 cases (Guilherme et al., 2013).  We were unable to demonstrate secondary 
instability in peripheral blood in our case, but this does not preclude the possibility 
in other tissues. However the multiple café au lait and white patches is indicative of 
an underlying mosaicism indicating instability of the ring chromosome in this tissue 
(even if not seen in the cultured blood). 
 
 
A previous review of all ring chromosome 17 cases, without MDCR involvement, 
showed shared common phenotypic features with no consistency in copy number 
losses (Charles et al., 1991; Surace et al., 2009). This observation is supported by 
our case, which in comparison to the only two other cases with a detailed 
description of epilepsy, showed a discrepant copy number loss (de Palma et al., 
2015; Ricard-Mousnier et al., 2007). It was suggested that alterations in gene 
expression (other than simply haploinsufficiency) could explain the common 
phenotypic features found in mild ring 17 syndrome (Surace et al., 2009). Variation 
in gene expression within or between tissues could arise either from ring 
chromosome instability in vivo (Wyandt, 1988) (Chudley et al., 1982) and/or as a 
result of telomere position effects resulting from juxtaposition of actively 
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transcribed sequences in proximity to telomere ends (as a result of ring formation), 
which may have an impact over long distances (Robin et al., 2014).   Additional 
cases, with more functional data, may lead to the identification of novel candidate 
epilepsy genes in ring chromosome 17 syndromes. 
 
Acknowledgements 
We would like to thank the parents for allowing us to report their daughter’s case. 
This work was undertaken at UCLH/UCL, which received a proportion of funding 
from the Department of Health’s NIHR Biomedical Research Centres funding 
scheme. The work was also supported by the Freemasons’ Grand Charity and  
Epilepsy Society. 
 
 
 
 
Figure1: a) array plot showing two CNVs on chromosome 17: a terminal deletion 
(red spots) which is pathogenic and a benign duplication (green spots); b) FISH 
preparation showing metaphase chromosomes.  Bluegnome BAC probe RP11-
567O16 (orange) which maps to 17q25.3 and Cytocell Aquarius subtelomeric probe 
for 17p (green); signals are consistent with deletion of RP11-567O16 on a ring 
chromosome identified as a ring chromosome 17 by the presence of a green (17p) 
signal.  The ring chromosome 17 replaces a normal chromosome 17. 
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c) UCSC snapshot of chromosome 17 showing the CNV of our case (red box). The 
black bar indicates a magnification of the CNV and below are reported the included 
genes. Red and blue bars indicate respectively deletions and duplications reported 
in Decipher and occurring in the same genomic area.  
  
 
Figure 2 (a,b,c,d): EEGs recorded at the age of 28 during an episode of non-
convulsive status epilepticus, represented by sub-continuous generalized spike and 
waves discharges. 
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